SCHEMBL13627233

SCHEMBL13627233

COCCOc1cc2nccc(Oc3ccc4c(ccn4C(=O)Nc4nccs4)c3)c2cc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.51
AXL P30530 3/20 0.41
AURKA O14965 7/20 0.41
MET P08581 7/20 0.41
AURKB Q96GD4 5/20 0.41
LCK P06239 5/20 0.41
LYN P07948 2/20 0.41
FLT1 P17948 2/20 0.41
PDGFRA P16234 2/20 0.41
BMPR1B O00238 1/20 0.41
PLK4 O00444 1/20 0.41
GAK O14976 1/20 0.41
EPHB6 O15197 1/20 0.41
RIPK2 O43353 1/20 0.41
STK10 O94804 1/20 0.41
ABL1 P00519 1/20 0.41
EGFR P00533 1/20 0.41
FYN P06241 1/20 0.41
CSF1R P07333 1/20 0.41
YES1 P07947 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1902592 0.89 KDR (0.49) KDRAXLAURKAMETAURKB
SCHEMBL12503719 0.88 KDR (0.43) KDRAXLMETFLT1PDGFRA
SCHEMBL1894686 0.87 KDR (0.64) KDRAXLAURKAMETAURKB
SCHEMBL1890585 0.84 KDR (0.57) KDRAXLAURKAMETAURKB
SCHEMBL13627390 0.84 KDR (0.49) KDRAXLAURKAMETAURKB
SCHEMBL1891016 0.79 KDR (0.43) KDRAXLAURKAMETAURKB
SCHEMBL1891671 0.78 KDR (0.42) KDRAXLMETFLT1EGFR
SCHEMBL5108381 0.76 KDR (0.47) KDR
SCHEMBL1889354 0.76 KDR (0.43) KDRAXLAURKAMETAURKB
SCHEMBL12411938 0.76 KDR (0.43) KDRAXLAURKAMETAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed